| Year |
Citation |
Score |
| 2020 |
Kennedy S, Swearingen CJ, Simsek I, Tambiah J. Factors driving change in WOMAC pain score: a post hoc analysis of a phase 2b trial of lorecivivint, a potential disease-modifying intra-articular treatment for knee osteoarthritis Osteoarthritis and Cartilage. 28. DOI: 10.1016/J.Joca.2020.02.568 |
0.305 |
|
| 2017 |
Yazici Y, McAlindon TE, Fleischmann R, Gibofsky A, Lane NE, Kivitz AJ, Skrepnik N, Armas E, Swearingen CJ, DiFrancesco A, Tambiah JRS, Hood J, Hochberg MC. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: Results of a 24-week, randomized, controlled, phase 1 study. Osteoarthritis and Cartilage. PMID 28711582 DOI: 10.1016/J.Joca.2017.07.006 |
0.303 |
|
| 2014 |
Yazici Y, Swearingen CJ. MBDA: what is it good for? Annals of the Rheumatic Diseases. 73: e72. PMID 25057179 DOI: 10.1136/Annrheumdis-2014-206252 |
0.302 |
|
| 2013 |
Kobayashi T, Kishimoto M, Swearingen CJ, Filopoulos MT, Ohara Y, Tokuda Y, Oshikawa H, Yoshida K, Utsunomiya M, Kimura M, Okada M, Matsui K, Yazici Y. Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Behçet's syndrome for patients in the US and Japan: data from a large, three-center cohort study. Modern Rheumatology / the Japan Rheumatism Association. 23: 547-53. PMID 22752504 DOI: 10.1007/S10165-012-0696-8 |
0.3 |
|
| 2012 |
Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, Swearingen CJ. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism & Related Disorders. 18: 230-3. PMID 22018910 DOI: 10.1016/J.Parkreldis.2011.10.006 |
0.486 |
|
| 2011 |
Swearingen CJ, Tilley BC, Adams RJ, Rumboldt Z, Nicholas JS, Bandyopadhyay D, Woolson RF. Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology. 37: 73-82. PMID 21894044 DOI: 10.1159/000330375 |
0.454 |
|
| 2010 |
Swearingen CJ, McCollum L, Daltroy LH, Pincus T, Dewalt DA, Davis TC. Screening for low literacy in a rheumatology setting: more than 10% of patients cannot read "cartilage," "diagnosis," "rheumatologist," or "symptom". Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 16: 359-64. PMID 21085021 DOI: 10.1097/Rhu.0B013E3181Fe8Ab1 |
0.33 |
|
| 2010 |
Swigris JJ, Yorke J, Sprunger DB, Swearingen C, Pincus T, du Bois RM, Brown KK, Fischer A. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease. Respiratory Medicine. 104: 1350-5. PMID 20471238 DOI: 10.1016/J.Rmed.2010.03.027 |
0.302 |
|
| 2010 |
Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM, Siegel EL, Yazici Y. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care & Research. 62: 181-9. PMID 20191516 DOI: 10.1002/Acr.20066 |
0.335 |
|
| 2009 |
Pincus T, Askanase AD, Swearingen CJ. A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheumatic Diseases Clinics of North America. 35: 819-27, x. PMID 19962626 DOI: 10.1016/J.Rdc.2009.10.017 |
0.33 |
|
| 2009 |
Pincus T, Swearingen CJ. The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care. Rheumatic Diseases Clinics of North America. 35: 787-98, ix. PMID 19962623 DOI: 10.1016/J.Rdc.2009.10.011 |
0.339 |
|
| 2009 |
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Archives of Neurology. 66: 1099-104. PMID 19597081 DOI: 10.1001/Archneurol.2009.159 |
0.529 |
|
| 2009 |
Pincus T, Swearingen CJ, Luta G, Sokka T. Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: A randomised, double-blind, placebo controlled withdrawal clinical trial Annals of the Rheumatic Diseases. 68: 1715-1720. PMID 19074913 DOI: 10.1136/Ard.2008.095539 |
0.32 |
|
| 2009 |
Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, Tilley BC. Minority enrollment in Parkinson's disease clinical trials. Parkinsonism & Related Disorders. 15: 258-62. PMID 18693062 DOI: 10.1016/J.Parkreldis.2008.06.005 |
0.511 |
|
| 2008 |
Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. The Journal of Rheumatology. 35: 2136-47. PMID 18793006 DOI: 10.3899/Jrheum.080182 |
0.339 |
|
| 2008 |
Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC. Caffeine and progression of Parkinson disease. Clinical Neuropharmacology. 31: 189-96. PMID 18670242 DOI: 10.1097/Wnf.0B013E31815A3F03 |
0.506 |
|
| 2005 |
Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, Pincus T. Long term safety of methotrexate in routine clinical care: Discontinuation is unusual and rarely the result of laboratory abnormalities Annals of the Rheumatic Diseases. 64: 207-211. PMID 15208176 DOI: 10.1136/Ard.2004.023408 |
0.308 |
|
| Show low-probability matches. |